Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (left eye)
ICD-10 E10.3542 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (left eye).
E10.3542 represents a complex condition where a patient with Type 1 diabetes mellitus experiences severe ocular complications, specifically proliferative diabetic retinopathy (PDR) leading to both traction and rhegmatogenous retinal detachments in the left eye. PDR is characterized by the growth of new blood vessels on the retina, which can lead to bleeding and scarring. The combined retinal detachments indicate that the retina has been pulled away from its normal position due to both the traction from the abnormal blood vessels and the presence of tears or holes in the retina. This condition requires urgent medical intervention, often involving surgical procedures such as vitrectomy or laser therapy to prevent permanent vision loss. Management of the underlying diabetes is crucial, as maintaining optimal blood glucose levels can help mitigate further complications. Regular monitoring of HbA1c levels is essential, with targets typically set below 7% to reduce the risk of diabetic complications.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, floaters, or sudden vision loss due to retinal detachment.
Ensure clear documentation of the type of retinal detachment and any surgical interventions performed.
Comprehensive diabetes management records, including HbA1c levels and treatment regimens.
Patients with poorly controlled diabetes presenting with complications.
Document the relationship between diabetes control and ocular health.
Used for treatment of proliferative diabetic retinopathy.
Document the extent of treatment and follow-up care.
Ophthalmologists should ensure clear documentation of the procedure and its necessity.
Specifying the type of retinal detachment is crucial for accurate coding and treatment planning, as it influences the management approach and potential outcomes.
Patients with diabetic retinopathy should have their HbA1c levels monitored at least every 3 to 6 months, depending on their treatment plan and stability of their diabetes.
